Please assess the completion status of the following clinical trial:

Trial Title: Cytoreduction and Intraperitoneal Chemotherapy Versus Systemic Chemotherapy in Colorectal Peritoneal Carcinomatosis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Metastatic disease to the peritoneum from colon or rectum (at least two isolated sites of disease)~* verified primary tumor of adenocarcinoma of the colon or rectum~* Potential resectability as judged by the treating surgeon~* Patient is available for follow-up according to the study protocol~* Signed informed consent~Exclusion Criteria:~* Extraabdominal metastases or liver metastases~* Paraaortic or other inoperable lymph node metastases~* Clear indication for surgery only (such as obstruction, bleeding or peritonitis)~* Prior treatment of either arm in the study~* Clinical or histopathological diagnosis of Peritoneal Pseudomyxoma~* Age \> 80~* Contraindications for chemotherapy~* Pregnancy or breastfeeding~* Ongoing infection

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Arm A: CRS plus postop intraperitoneal chemotherapy. (Type: EXPERIMENTAL): Cytoreductive surgery and postoperative intraperitoneal chemotherapy.
- Arm B: Systemic chemotherapy alone (Type: ACTIVE_COMPARATOR): Systemic chemotherapy alone

Based on this trial design, predict the completion outcome and termination type (if applicable).